Clinical Considerations on Anticoagulation Management in Cardiovascular Diseases During Pregnancy

被引:1
作者
Goland, Sorel [1 ]
Zilberman, Liaz [1 ]
Elkayam, Uri [2 ]
机构
[1] Kaplan Med Ctr, Dept Cardiol, IL-76100 Rehovot, Israel
[2] Univ So Calif, Dept Med, Div Cardiovasc Dis, Los Angeles, CA USA
关键词
anticoagulation; pregnancy; cardiovascular diseases; MOLECULAR-WEIGHT HEPARIN; MECHANICAL HEART-VALVES; MASSIVE PULMONARY-EMBOLISM; TISSUE-PLASMINOGEN ACTIVATOR; VENOUS THROMBOEMBOLISM; PERIPARTUM CARDIOMYOPATHY; HEMOSTATIC CHANGES; RISK-FACTORS; WOMEN; WARFARIN;
D O I
10.1002/ddr.21113
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pregnancy-associated thrombosis is an important cause of morbidity and mortality during pregnancy. All anticoagulation options are associated with risks and benefits. Thus, although anticoagulation therapy is an important component of the management of thrombotic complications in pregnancy, it is associated with fetal and maternal complications. Therefore, pregnancy poses a serious therapeutic dilemma for both physicians and their patients. This review summarizes the available data on anticoagulation therapy for thromboembolic prophylaxis in pregnant women focusing on cardiovascular disorders, especially on treatment strategy in pregnant women with mechanical heart valves. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:541 / 552
页数:12
相关论文
共 121 条
[21]   Pulmonary embolism in pregnancy [J].
Bourjeily, Ghada ;
Paidas, Michael ;
Khalil, Hanan ;
Rosene-Montella, Karen ;
Rodger, Marc .
LANCET, 2010, 375 (9713) :500-512
[22]  
Box LC, 2004, TEX HEART I J, V31, P442
[23]   PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS HEPARIN DURING THE EARLY 3RD TRIMESTER OF PREGNANCY [J].
BRANCAZIO, LR ;
ROPERTI, KA ;
STIERER, R ;
LAIFER, SA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) :1240-1245
[24]   Haemostatic changes in pregnancy [J].
Bremme, KA .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (02) :153-168
[25]   Haemostatic changes in pregnancy [J].
Brenner, B .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :409-414
[26]  
Briggs G.G., 2008, DRUGS PREGNANCY LACT, V8th
[27]   EFFECT OF PREGNANCY ON PRESSURE-GRADIENT IN MITRAL-STENOSIS [J].
BRYG, RJ ;
GORDON, PR ;
KUDESIA, VS ;
BHATIA, RK .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (05) :384-386
[28]   Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy [J].
Casele, HL ;
Laifer, SA ;
Woelkers, DA ;
Venkataramanan, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) :1113-1117
[29]   Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery [J].
Casele, Holly ;
Grobman, William A. .
OBSTETRICS AND GYNECOLOGY, 2006, 108 (03) :535-540
[30]   Bone density changes in women who receive thromboprophylaxis in pregnancy [J].
Casele, Holly ;
Haney, Elaine I. ;
James, Andra ;
Rosene-Montella, Karen ;
Carson, Michael .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (04) :1109-1113